ABCL
AbCellera Biologics, Inc
Halal Rating :
See Details
Last Price
$4.43
Last updated:
Market Cap
$1.62b
7D Change
3.03%
1 Year Change
-41.36%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Nov. 7, 2023
AbCellera Biologics Inc. develops an antibody discovery platform. The company is headquartered in Vancouver, Canada.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2023 | $10.06m | $61.45m | $10.78m | - | 107.19% | 0.00% |
| March 31, 2023 | $12.19m | $77.07m | $9.76m | $16.73m | 80.04% | 21.70% |
| Dec. 31, 2022 | $21.55m | $59.32m | - | $11.39m | 0.00% | 19.20% |
Company Impact
Help us evaluate AbCellera Biologics, Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.